Literature DB >> 2077410

Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.

M Goldman1, P Vandenabeele, J Moulart, Z Amraoui, D Abramowicz, J Nortier, J L Vanherweghem, W Fiers.   

Abstract

Interleukin-6 (IL-6) was determined in serum and peritoneal dialysis effluent (PDE) of patients on chronic ambulatory peritoneal dialysis (CAPD) by a biological assay measuring the proliferation of the IL-6-dependent 7TD1 cell line. Six patients free of peritonitis displayed low but significant levels of IL-6 (mean +/- 42 pg/ml) in PDE, while IL-6 was undetectable in serum. In 6 patients with staphylococcal peritonitis, a tremendous increase in PDE levels of IL-6 was noted (range: 5,832-37,491 pg/ml), while serum IL-6 remained either undetectable or on a low level except in one case. After 5 days of antibiotic treatment, IL-6 levels in PDE returned to basal values. We conclude that CAPD results in an intraperitoneal secretion of IL-6 which is markedly but transiently increased during peritonitis episodes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2077410     DOI: 10.1159/000186154

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  11 in total

1.  The Mutual Relationship Between Peritonitis and Peritoneal Transport.

Authors:  Sadie van Esch; Anouk T N van Diepen; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

2.  Direct activation of human peritoneal mesothelial cells by heat-killed microorganisms.

Authors:  P Kinnaert; J P De Wilde; B Bournonville; C Husson; I Salmon
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

3.  IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane.

Authors:  Rusan Catar; Janusz Witowski; Nan Zhu; Christian Lücht; Alicia Derrac Soria; Javier Uceda Fernandez; Lei Chen; Simon A Jones; Ceri A Fielding; Andras Rudolf; Nicholas Topley; Duska Dragun; Achim Jörres
Journal:  J Am Soc Nephrol       Date:  2016-11-11       Impact factor: 10.121

4.  Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells.

Authors:  T Rampino; G Cancarini; M Gregorini; P Guallini; M Maggio; A Ranghino; G Soccio; A Dal Canton
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Authors:  Ryo Yamamoto; Yasushi Otsuka; Masaaki Nakayama; Yukio Maruyama; Naohiko Katoh; Masato Ikeda; Hiroyasu Yamamoto; Keitaro Yokoyama; Yoshindo Kawaguchi; Masato Matsushima
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

Review 6.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

7.  Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha.

Authors:  N Topley; Z Brown; A Jörres; J Westwick; M Davies; G A Coles; J D Williams
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

8.  Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis.

Authors:  Y C Ko; N Mukaida; T Kasahara; S Muto; K Matsushima; E Kusano; Y Asano; Y Itoh; Y Yamagishi; T Kawai
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

9.  Peritoneal protein losses and cytokine generation in automated peritoneal dialysis with combined amino acids and glucose solutions.

Authors:  H L Tjiong; F J Zijlstra; T Rietveld; J L Wattimena; J G M Huijmans; G R Swart; M W J A Fieren
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

10.  Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.

Authors:  Hayriye Sayarlioglu; Cevat Topal; Mehmet Sayarlioglu; Haluk Dulger; Ekrem Dogan; Reha Erkoc
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.